See also this year's filing and all EDGAR filings for this company.
PDF Report 0001328143_2021_Adamas_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001328143, Adamas Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 111,736,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,598,000 |
| 3 | remainder_Assets | 6,695,000 |
| 4 | LiabilitiesCurrent | 34,867,000 |
| 5 | LiabilitiesNoncurrent | 135,138,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,990,996 |
| 8 | SellingGeneralAndAdministrativeExpense | 97,299,341 |
| 9 | ResearchAndDevelopmentExpense | 953,455 |
| 10 | remainder_Expenses | 13,163,961 |
| 11 | remainder_Revenues | 70,579,775 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 214,946 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 120,029,000 |
| 1 | Liabilities | 170,005,000 |
| 2 | Expenses | 113,407,753 |
| 3 | Revenues | 70,579,775 |
| 4 | StockholdersEquity | -49,976,000 |
| 5 | NetIncome | -42,827,978 |
| 6 | ComprehensiveNetIncome | -42,720,505 |
| 7 | BaseVar | 237,118,237 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.05 |
| 9 | EconomicCapitalRatio | 1.29 |
Edgar->Model Mapping
Feature Distribution
Change over Time
